4 ms·
I bet Astrazeneca/Oxford is regretting offering to produce at cost due to the level of grief and politicking coming from EU capitals and the EU commission.
by a_humean 6y ago
I bet Astrazeneca/Oxford is regretting offering to produce at cost due to the level of grief and politicking coming from EU capitals and the EU commission.
- fenk85 6y agoThey didnt show any regret when taking hundreds of millions and making promises that they seem to knew they could not keep.
- supergirl 6y agoit just means they don't make a profit, officially, right? but they get paid to cover everything: workforce, R&D, opening extra plants, bonuses for executives, etc. I'm sure it's practically no different. just accounting magic. just the fact that they get paid to ramp up production is enough win. they'll leverage this to make profit later.
- a_humean 6y agoI just mean that if you name is going to get dragged through the mud you can forgive the feeling that maybe they should a profit out of it. All of their competitors are recording record profits from vaccine sales. Their only silver lining is they have sold a $250 million USD stake in Moderna for $1 billion this month.